StartUp Health community member Robin Roberts, CEO & founder of datosX, joined us for a Health Moonshot Update to share how the company supports digital health tech companies in validating their technologies through cost-effective, efficient trials. The approach pairs these companies with healthcare systems, helping them run studies and gather critical data for FDA submission and market validation. datosX’s model stands out by including healthcare systems as active participants in pilot projects, providing them with valuable data while allowing the digital health companies to test their solutions in real-world settings. Additionally, the company leverages AI, specifically its EVIDIA platform, to provide more precise insights for digital health tech companies.

🌍 Global Health Tech Collaboration: datosX connects digital health companies with healthcare systems to test and validate their solutions, creating a two-sided network that benefits both parties. Healthcare systems can run trials for new technologies while digital health companies gain validation and data needed for FDA submission and market credibility.

💡 Efficient, Cost-Effective Trials: By partnering with healthcare systems, datosX reduces the costs of running trials, making the process 5-8 times cheaper compared to traditional clinical research organizations (CROs). This allows smaller companies to validate their technologies in a timely and cost-efficient manner.

📊 AI-Powered Platform: EVIDIA, datosX's AI platform, enables digital health companies to gain insights into trends and validation data for their technologies. It uses both public and non-public data to provide deep, tailored analysis, guiding companies in their path to market.

🔬 End-to-End Validation Services: datosX supports companies throughout the entire process—helping them design the study, execute it with healthcare systems, analyze the data, and prepare FDA submission packages or clinical reports, all with rigorous protocols.

🤝 Healthcare System Involvement: Unlike traditional models where healthcare systems are passive participants, datosX’s approach involves them actively in the decision-making process, allowing them to opt in to trials based on their specific priorities and offering reimbursement for study execution costs.